A new study by the American Medical Association (AMA) reveals that despite an almost 40 percent decrease in opioid prescriptions, overdose deaths are on the rise. What is contributing to this, and what changes can independent physicians expect to see in the future of substance abuse treatment?
More: Blog
Due to the difficulty and complexity of “finding, accessing, and paying for healthcare in America,” half of consumers have avoided care. What does the data tell us about patients’ expectations for price transparency, digital tools, and the post-pandemic future of healthcare?
As more millennials become parents or grow their families, today’s pediatricians must understand millennial parents’ healthcare preferences. We examine the data and research to uncover ways pediatricians can attract and retain patients while enhancing their healthcare experience.
How can technology and clinical informatics enhance pediatricians’ workflows and patient engagement? Nele Jessel, MD, FAAP, Vice President of Clinical Informatics at Privia Health, shares ways pediatricians can modernize their practice.
As healthcare consolidation continues, health systems are exploring “complementary mergers” to enhance their capabilities. Frank Letherby, CEO, Privia Medical Group — Florida, offers insights into how leaders can unite and align employed and independent physicians.
The COVID-19 pandemic has increased demand for digital behavioral health care to increase accessibility and help reduce the costs of traveling to the doctor’s office. See how this market is expected to grow during and after COVID-19.
New population health data from CMS shows which patients are most affected by COVID-19. How might insights such as these advance value-based care and alternative payment models?
Self-funded insurance is one way for employers to decrease healthcare spending while promoting employee well-being. How can high-performance networks and technology engage patients while further lowering costs?
The Centers for Medicare and Medicaid Services (CMS) is updating its rules to encourage states, payers, and Medicare programs to enter value-based payment arrangements (VPA) with drug manufacturers to help reduce drug costs. What does this mean for Medicare providers and beneficiaries?
As tech companies develop digital tools to slow the spread of COVID-19, a recent report raises concerns about whether these apps protect patient data. What are the main concerns? How are industry and federal lawmakers working to protect users?